IP Library Granted Patent US 8,835,495
Granted Patent B2
US 8,835,495 · App. 12/227,971 · Granted Sep 16, 2014

Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association

Inventors: Dante Alario Júnior (Säo Paulo, BR); Julio Cesar Gagliardi (Säo Paulo, BR)
Assignee: Incrementha P, D & I Pesquisa, Desenvolvimento e Inovacao de Farmacos e Medicamentos Ltda
A61K31/135A61K31/216
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,835,495
App. No.
12/227,971
Granted
Sep 16, 2014
Kind
B2
Abstract

The present invention relates to an association of active ingredients. More specifically: to an association of cyclobenzaprine and aceclofenac. Additionally, the present invention is also related to the use of aceclofenac and cyclobenzaprine, in association for the preparation of a medicine useful in the treatment of painful muscular diseases, as well as to a method of treatment of painful muscular diseases using an association of aceclofenac and cyclobenzaprine.

Claims (10)

1. A pharmaceutical composition comprising:

(a) cyclobenzaprine or its salts;

(b) aceclofenac or its salts; and

(c) optionally one or more pharmaceutically acceptable excipients;

wherein said pharmaceutical composition comprises cyclobenzaprine and aceclofenac in a single dosage unit in the form of tablet or hard capsule; and wherein said cyclobenzaprine is not in contact with said aceclofenac.

2. The pharmaceutical composition of claim 1 , wherein said tablet is a multilayer tablet in which the layer comprising cyclobenzaprine is physically separated from the layer comprising aceclofenac by an isolating intermediate layer.

3. The pharmaceutical composition of claim 1 , wherein said capsule comprises:

(a) cyclobenzaprine in the form of granules or tablets; and

(b) aceclofenac in the form of granules or tablets;

wherein said cyclobenzaprine or aceclofenac granules or tablets are coated.

Assignments (3)
CHANGE OF NAME Recorded Nov 5, 2015
From: EUROFARMA LABORATORIOS LTDA.
To: EUROFARMA LABORATORIOS S.A.
Reel/Frame 037054/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2015
From: INCREMENTHA P, D & I PESQUISA, DESENVOLVIMENTO E INOVACAO DE FARMACOS E MEDICAMENTOS LTDA
To: EUROFARMA LABORATORIOS LTDA; BIOLAB SANUS FARMACEUTICA LTDA.
Reel/Frame 036958/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2009
From: JUNIOR, DANTE ALARIO; GAGLIARDI, JULIO CESAR
To: INCREMENTHA P, D & I PESQUISA, DESENVOLVIMENTO E INOVACAO DE FARMACOS E MEDICAMENTOS LTDA
Reel/Frame 022705/0487 →
Priority Claims (1)
BR 0602179 · Jun 8, 2006 · national
Continuity (1)
Related Publication 20090306204A1 · Dec 10, 2009